These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 12675764)
1. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor. Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764 [TBL] [Abstract][Full Text] [Related]
2. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors. Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557 [TBL] [Abstract][Full Text] [Related]
3. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Charles AK; Brown KW; Berry PJ Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048 [TBL] [Abstract][Full Text] [Related]
4. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor]. Jiang YP; Shen Y; Sun N; Wang H Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811 [TBL] [Abstract][Full Text] [Related]
5. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor. Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892 [TBL] [Abstract][Full Text] [Related]
6. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients. Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260 [TBL] [Abstract][Full Text] [Related]
7. Identical genetic changes in different histologic components of Wilms' tumors. Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107 [TBL] [Abstract][Full Text] [Related]
9. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation. Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820 [TBL] [Abstract][Full Text] [Related]
10. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774 [TBL] [Abstract][Full Text] [Related]
11. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker. Roberts DJ; Haber D; Sklar J; Crum CP Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523 [TBL] [Abstract][Full Text] [Related]
12. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor. Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548 [TBL] [Abstract][Full Text] [Related]
13. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein. Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252 [TBL] [Abstract][Full Text] [Related]
14. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology. Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575 [TBL] [Abstract][Full Text] [Related]
16. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
17. Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours. Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644 [TBL] [Abstract][Full Text] [Related]
20. Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation. Lugtenberg RT; Cransberg K; Loos WJ; Wagner A; Alders M; van den Heuvel-Eibrink MM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1039-44. PubMed ID: 18273617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]